Marksans Pharma Ltd
Ticker: MARKSANS
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
180.71
Market Cap
8189.12
Debt/Equity
0.1293
ROE %
16.636
PB
3.2896
Promoter %
43.874
Pledge %
0.000
1Y Rev Growth %
20.890
5Y Rev Growth %
18.875
NP Margin %
14.131
NP Margin 5Y Avg %
14.249
Trading Reference
1M Return %
4.537
6M Return %
-14.360
1Y Return %
-38.649
% Away 52W High
98.495
% Away 52W Low
11.549
Daily Volume
1285514
Investment Verdict
Hold
Score 70/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 26/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Marksans Pharma Ltd is currently trading near a key support level, with recent price action showing increased volume on upward moves, suggesting potential for a rebound. However, resistance levels above may limit upside potential in the medium term.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
B
Balu Forge Industries Ltd
Balu Forge Industries Ltd shows potential in a growing sector, but faces challenges in consistency and valuation. Investors should proceed with caution.
View details
R
Rattanindia Enterprises Ltd
Rattanindia Enterprises Ltd shows potential but faces significant challenges in growth consistency and profitability metrics.
View details
G
Gujarat Pipavav Port Ltd
Gujarat Pipavav Port Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
View details
M
Mahindra Lifespace Developers Ltd
Mahindra Lifespace Developers Ltd shows potential for growth but faces challenges in profitability and valuation compared to peers.
View details
T
Triveni Engineering and Industries Ltd
Triveni Engineering shows potential for growth but faces several risks that could impact its performance. Investors should proceed with caution.
View details
R
RRP Semiconductor Ltd
RRP Semiconductor Ltd shows potential for growth in a promising sector, but faces challenges in valuation and execution risks.
View details
P
PNC Infratech Ltd
PNC Infratech Ltd shows potential for growth in the infrastructure sector, but faces challenges in profitability and execution risks.
View details
E
Ellenbarrie Industrial Gases Ltd
Ellenbarrie Industrial Gases Ltd shows potential in a growing sector, but faces challenges in profitability and valuation, making it a risky investment.
View details
G
Garware Technical Fibres Ltd
Garware Technical Fibres Ltd shows decent potential with consistent growth and profitability metrics, though some risks in execution and liquidity should be monitored.
View details
G
Garware Hi-Tech Films Ltd
Garware Hi-Tech Films Ltd shows decent fundamentals with consistent growth and profitability, but faces some risks in execution and governance.
View details
E
Epigral Ltd
Epigral Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
View details
K
Keystone Realtors Ltd
Keystone Realtors Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
R
RedTape
RedTape shows potential but faces challenges in growth and valuation metrics. Caution is advised.
View details
T
Tips Music Ltd
Tips Music Ltd shows potential in a growing sector, but faces significant challenges in profitability and valuation metrics.
View details
B
Black Box Ltd
Black Box Ltd shows potential for growth but faces challenges in profitability and market sentiment.
View details
M
Mastek Ltd
Mastek Ltd shows decent potential with strong growth and profitability metrics, but some risks in governance and execution should be monitored.
View details
Business Overview
Marksans Pharma Ltd is a prominent player in the Indian pharmaceutical sector, dedicated to delivering high-quality generic and specialty medicines. Catering to both domestic and international markets, the company focuses on innovation and compliance with global standards. Its commitment to research and development ensures a robust pipeline of products, making it a reliable choice for healthcare providers and patients alike.
- Established leader in the Indian pharma industry
- Wide range of generic and specialty products
- Strong focus on R&D and innovation
- Compliance with global quality standards
- Expanding international presence
- Commitment to improving patient health outcomes
Investment Thesis
Marksans Pharma Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company for sustained growth and profitability in the evolving pharmaceutical landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment offers a robust growth runway.
- Valuation metrics indicate Marksans is attractively priced compared to industry peers.
- Focus on innovation and R&D supports long-term competitive advantage.
- Solid financial performance and consistent revenue growth underline investment potential.
Opportunity vs Risk
Opportunities
- Growing demand for generic medicines
- Expansion into international markets
- Strong product pipeline
- Strategic partnerships with healthcare firms
Risks ⚠️
- Regulatory challenges in pharmaceuticals
- Intense competition in the sector
- Currency fluctuations affecting exports
- Dependence on key markets for revenue
Peer Perspective
Marksans Pharma Ltd trades at a discount to peers like Sun Pharmaceutical and Dr. Reddy's Laboratories, but a sustained improvement in margin stability could trigger a rerating, aligning its valuation more closely with industry leaders.
Future Outlook
Marksans Pharma Ltd is well-positioned for growth, driven by expanding product pipelines and market reach. Successful execution of strategic initiatives and effective cost control will be crucial to realizing its full potential.
AI FAQs for Retail Users
- Q: What does Marksans Pharma Ltd do?A: Marksans Pharma Ltd is a pharmaceutical company engaged in manufacturing and marketing generic medicines.
- Q: Is Marksans Pharma Ltd a good investment?A: Investing in stocks carries risks. Research and consider your financial goals before investing.
- Q: What are the recent developments for Marksans Pharma Ltd?A: Stay updated with company news and announcements for the latest developments and performance.
- Q: How can I buy Marksans Pharma Ltd shares?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What factors affect Marksans Pharma Ltd's stock price?A: Stock prices can be influenced by market trends, company performance, and economic conditions.
📊 Stock Investment Checklist (100 Points)
Marksans Pharma Ltd • Updated: 2025-09-17 15:55:01
-
10BusinessHighPharmaceutical sector shows growth potential, but competition is high.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are moderate, cash flow is stable.
-
8ValuationHighP/E ratio is higher than industry average, indicating overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
6GovernanceGoodPromoter holding is decent, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is neutral, with low liquidity.
Final Score & Verdict
Score 48 / 100
• Decent
Marksans Pharma Ltd shows potential but faces challenges in growth consistency and valuation. Caution is advised.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 68/100